title: Comment: Is 3,4-DAP a new option in treating MuSK MG?
authors.affiliation: From the Department of Neurology/Neuromuscular Division, Duke University, Durham, NC.
authors.forename: Lisa D
authors.initials: LD
authors.lastname: Hobson-Webb
mesh_terms: D015761:4-Aminopyridine / Q000031:analogs & derivatives*; D001323:Autoantibodies / Q000097:blood*; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis / Q000097:blood* / Q000188:drug therapy*; D020794:Receptor Protein-Tyrosine Kinases / Q000097:blood*; D011950:Receptors, Cholinergic / Q000097:blood*
chemical_list: D001323:Autoantibodies; D011950:Receptors, Cholinergic; D015761:4-Aminopyridine; D020794:Receptor Protein-Tyrosine Kinases